trending Market Intelligence /marketintelligence/en/news-insights/trending/3rr0idckbo4kknr0wdly5g2 content esgSubNav
In This List

OptimizeRx names board members

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


OptimizeRx names board members

OptimizeRx Corp. appointed Patrick Spangler and Bryan Archambault to its board.

Spangler succeeds Jack Pinney, who was appointed the head of the company's medical advisory board. Spangler is the CFO of VigiLanz, a digital healthcare intelligence firm, and is a board member of Lifespace Communities.

Archambault replaces Lynn O'Connor Vos as representative of WPP, a strategic investor in OptimizeRx. Archambault serves as the chief marketing officer of WPP unit greyhealth group, or ghg, Kansas City.

Vos left her position as CEO of greyhealth group to become CEO of the Muscular Dystrophy Association. She will remain on OptimizeRx's board as an independent director.

Rochester, Mich.-based OptimizeRx provides digital health messaging services, providing a direct channel for pharmaceutical companies to communicate with healthcare providers.